FRONTIER CAPITAL MANAGEMENT CO LLC - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 160 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRONTIER CAPITAL MANAGEMENT CO LLC ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$4,550,000
-30.7%
399,103
-2.6%
0.04%
-25.0%
Q2 2021$6,562,000
-15.1%
409,879
-5.2%
0.05%
-17.2%
Q1 2021$7,727,000
+22.5%
432,373
-7.4%
0.06%
+23.4%
Q4 2020$6,306,000
+2.7%
466,765
-10.6%
0.05%
-13.0%
Q3 2020$6,142,000
-17.7%
521,869
+3.2%
0.05%
-18.2%
Q2 2020$7,466,000
+31.5%
505,846
+20.3%
0.07%
+3.1%
Q1 2020$5,677,000
-56.8%
420,539
-22.7%
0.06%
-34.0%
Q4 2019$13,154,000
+25.3%
544,215
-0.4%
0.10%
+18.3%
Q3 2019$10,501,000
+9.0%
546,356
+67.6%
0.08%
+12.3%
Q2 2019$9,635,000
-37.7%
326,063
+0.2%
0.07%
-33.6%
Q1 2019$15,465,000
+276.2%
325,572
+185.9%
0.11%
+233.3%
Q4 2018$4,111,000
-87.9%
113,873
-79.4%
0.03%
-84.9%
Q3 2018$34,052,000
+37.9%
553,245
+51.4%
0.22%
+25.1%
Q2 2018$24,685,000365,4350.18%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 246,563$2,244,0001.36%
LEVIN CAPITAL STRATEGIES, L.P. 1,435,876$13,066,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,695,020$42,725,0000.96%
DCF Advisers, LLC 189,565$1,725,0000.76%
DAFNA Capital Management LLC 289,040$2,630,0000.68%
RICE HALL JAMES & ASSOCIATES, LLC 1,678,609$15,275,0000.61%
Rhenman & Partners Asset Management AB 589,200$5,362,0000.53%
PFM Health Sciences, LP 1,088,566$9,906,0000.37%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$2,819,0000.36%
Granahan Investment Management 1,588,944$14,459,0000.36%
View complete list of AERIE PHARMACEUTICALS INC shareholders